616 related items for PubMed ID: 29421774
1. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
Hoseini R, Sabzian K, Otukesh H, Zafaranloo N, Panahi P, Rahimzadeh N, Nakhaie S, Akhavan Sepehi M.
Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774
[Abstract] [Full Text] [Related]
2. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Jan; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
3. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Büscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tönshoff B, Hoyer PF, Konrad M, Weber S, German Pediatric Nephrology Association (GPN).
Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):245-53. PubMed ID: 26668027
[Abstract] [Full Text] [Related]
4. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
Wannous H.
Pediatr Nephrol; 2024 Aug 05; 39(8):2413-2422. PubMed ID: 38587559
[Abstract] [Full Text] [Related]
5. Rituximab for nephrotic syndrome in children.
Iijima K, Sako M, Nozu K.
Clin Exp Nephrol; 2017 Apr 05; 21(2):193-202. PubMed ID: 27422620
[Abstract] [Full Text] [Related]
6. Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome.
Mason AE, Sen ES, Bierzynska A, Colby E, Afzal M, Dorval G, Koziell AB, Williams M, Boyer O, Welsh GI, Saleem MA, UK RaDaR/NephroS Study.
Clin J Am Soc Nephrol; 2020 Jul 01; 15(7):983-994. PubMed ID: 32317330
[Abstract] [Full Text] [Related]
7. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.
Taşdemir M, Canpolat N, Yıldız N, Özçelik G, Benzer M, Saygılı SK, Özkayin EN, Türkkan ÖN, Balat A, Candan C, Çelakıl M, Yavuz S, Akıncı N, Göknar N, Akgün C, Tülpar S, Alpay H, Sever FL, Bilge İ.
Turk J Med Sci; 2021 Aug 30; 51(4):1781-1790. PubMed ID: 33581711
[Abstract] [Full Text] [Related]
8. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.
Pediatr Nephrol; 2008 Aug 30; 23(8):1269-79. PubMed ID: 18465150
[Abstract] [Full Text] [Related]
9. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K.
Pediatr Nephrol; 2019 Feb 30; 34(2):353-357. PubMed ID: 30426219
[Abstract] [Full Text] [Related]
10. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
Ravani P, Bonanni A, Ghiggeri GM.
BMJ Open; 2017 Mar 17; 7(3):e013319. PubMed ID: 28314744
[Abstract] [Full Text] [Related]
11. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study.
Sheashaa H, Mahmoud I, El-Basuony F, El-Husseini A, Hassan N, El-Baz M, Ahmed NS, Sobh M.
Int Urol Nephrol; 2007 Mar 17; 39(3):923-8. PubMed ID: 17447154
[Abstract] [Full Text] [Related]
12. Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review.
Jellouli M, Charfi R, Maalej B, Mahfoud A, Trabelsi S, Gargah T.
J Pediatr; 2018 Jun 17; 197():191-197.e1. PubMed ID: 29680473
[Abstract] [Full Text] [Related]
13. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, Fu H, Du L, Liu A.
Pediatr Nephrol; 2012 Nov 17; 27(11):2073-2079. PubMed ID: 22714672
[Abstract] [Full Text] [Related]
14. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
Ladapo TA, Esezobor CI, Lesi FE.
Pan Afr Med J; 2016 Nov 17; 25():258. PubMed ID: 28293374
[Abstract] [Full Text] [Related]
15. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
Webb H, Jaureguiberry G, Dufek S, Tullus K, Bockenhauer D.
Pediatr Nephrol; 2016 Apr 17; 31(4):589-94. PubMed ID: 26525199
[Abstract] [Full Text] [Related]
16. Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).
Nozu K, Sako M, Tanaka S, Kano Y, Ohwada Y, Morohashi T, Hamada R, Ohtsuka Y, Oka M, Kamei K, Inaba A, Ito S, Sakai T, Kaito H, Shima Y, Ishikura K, Nakamura H, Nakanishi K, Horinouchi T, Konishi A, Omori T, Iijima K.
Clin Exp Nephrol; 2024 Apr 17; 28(4):337-348. PubMed ID: 38010466
[Abstract] [Full Text] [Related]
17. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
Tenbrock K, Müller-Berghaus J, Fuchshuber A, Michalk D, Querfeld U.
Pediatr Nephrol; 1998 Aug 17; 12(6):459-62. PubMed ID: 9745868
[Abstract] [Full Text] [Related]
18. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K, Słowiaczek E, Kwinta-Rybicka J, Wilkosz K, Drozdz D, Nowak J.
Przegl Lek; 1996 Aug 17; 53(4):365-8. PubMed ID: 8711193
[Abstract] [Full Text] [Related]
19. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 17; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
20. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
Hamasaki Y, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Ito S, Kaneko T, Honda M, for Japanese Study Group of Renal Disease in Children.
Pediatr Nephrol; 2013 May 17; 28(5):765-71. PubMed ID: 23314441
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
